Heart Failure Clinical Trials in Columbus, Ohio
8 studies are recruiting for heart failure in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, and with at least one additional risk factor for HF. The study will include an optional pre-screenin…
- Stage
- Phase 3
- Ages
- 40 and older
- Site
- Research Site, Columbus, Ohio
- Locations
- 957 in total
- Run by
- AstraZeneca
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejec…
- Stage
- Not phased
- Ages
- 21 and older
- Site
- The Ohio State University, Columbus, Ohio
- Locations
- 50 in total
- Run by
- Procyrion
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
- Stage
- Not phased
- Ages
- Any age
- Site
- Research site, Columbus, Ohio
- Locations
- 333 in total
- Run by
- Medtronic
-
Assessment of CCM in HF With Higher Ejection Fraction
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Ohio State University Wexner Medical Center, Columbus, Ohio
- Locations
- 105 in total
- Run by
- Impulse Dynamics
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Ohio State University, Columbus, Ohio
- Locations
- 12 in total
- Run by
- VDI Technologies
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- The Ohio State University, Columbus, Ohio
- Locations
- 92 in total
- Run by
- Cardiac Dimensions, Inc.
-
Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
Magnetic resonance elastography is a novel non-invasive MRI technique to obtain stiffness of soft tissues such as liver, heart, kidneys, etc. In this imaging technique a person is laid in an MR scanner and a paddle (plastic drum) is put on the area of interest to send sound vibration via a speaker …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- The Ohio State University Wexner Medical Center, Columbus, Ohio
- Run by
- Arunark Kolipaka
-
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
- Stage
- Not phased
- Ages
- 22 and older
- Site
- The Ohio State University, Columbus, Ohio
- Locations
- 45 in total
- Run by
- Cordio Medical
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.